- lipodystrophy,
approved initially in 2010. It is
produced and
developed by
Theratechnologies, Inc. of Canada. The drug is a
synthetic peptide consisting of all...
-
McGill University.
Since 1996, he has been
chairman of the
board of
Theratechnologies, a
Canadian biopharmaceutical company. Grandpré
turned 100 in September...
-
unresectable Stage III non-small cell lung
cancer Ibalizumab-uiyk
Theratechnologies human immunodeficiency virus type 1 (HIV-1)
infection Brentuximab...
-
Limited ITX The
North West
Company Inc. NWC The
Stars Group Inc. TSGI
Theratechnologies Inc. TH
Thomson Reuters Corporation TRI
Tidewater Midstream and Infrastructure...
-
applicable to
judicial review proceedings or to
appellate standards – –
Theratechnologies inc v 121851
Canada inc 2015 SCC 18 [75]
Securities and statutory...
-
Pharmaceutical Servier Sobi
Sunovion Takeda Pharmaceutical Company Theratechnologies Valeo Pharma Vantage Biotrials Former members include Actelion, Almirall...
-
Carey v Laiken, 2015 SCC 17 [18]
December 10, 2014
April 16, 2015
Theratechnologies inc v 121851
Canada inc, 2015 SCC 18 [19]
December 1, 2014
April 17...
- GlaxoSmithKline. He was a
scientific advisor and
collaborator for
Theratechnologies, a
Canadian biotechnology company that
developed Egrifta, the only...
-
trials for
major pharmaceutical sponsors including Pfizer, Merck,
Theratechnologies, Schering-Plough, Tibotec, NeurogesX,
National Institutes of Health...
